Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term receptor. Found 70 abstracts

paginate
Mookerjee-Basu J, Kappes DJ. iNKT cells do a fat lot of good. Nature immunology. 2017 Jan;18(1):10-2.
Rizzolio F, Caligiuri I, Lucchetti C, Fratamico R, Tomei V, Gallo G, Agelan A, Ferrari G, Toffoli G, Klein-Szanto AJ, Giordano A. Dissecting Pin1 and phospho-pRb regulation. Journal of cellular physiology. 2013 Jan;228(1):73-7.   PMCID: not NIH funded
Cao Y, Marks JD, Huang Q, Rudnick SI, Xiong CY, Hittelman WN, Wen XX, Marks JW, Cheung LH, Boland K, Li C, Adams GP, Rosenblum MG. Single-Chain Antibody-Based Immunotoxins Targeting Her2/neu: Design Optimization and Impact of Affinity on Antitumor Efficacy and Off-Target Toxicity. Molecular Cancer Therapeutics. 2012 Jan;11(1):143-53.
Couch FJ, Gaudet MM, Antoniou AC, Ramus SJ, Kuchenbaecker KB, Soucy P, Beesley J, Chen XQ, Wang XS, Kirchhoff T, McGuffog L, Barrowdale D, Lee A, Healey S, Sinilnikova OM, Andrulis IL, Ozcelik H, Mulligan AM, Thomassen M, Gerdes AM, Jensen UB, Skytte AB, Kruse TA, Caligo MA, von Wachenfeldt A, Barbany-Bustinza G, Loman N, Soller M, Ehrencrona H, Karlsson P, Nathanson KL, Rebbeck TR, Domchek SM, Jakubowska A, Lubinski J, Jaworska K, Durda K, Zlowocka E, Huzarski T, Byrski T, Gronwald J, Cybulski C, Gorski B, Osorio A, Duran M, Tejada MI, Benitez J, Hamann U, Hogervorst FB, van Os TA, van Leeuwen FE, Meijers-Heijboer HE, Wijnen J, Blok MJ, Kets M, Hooning MJ, Oldenburg RA, Ausems M, Peock S, Frost D, Ellis SD, Platte R, Fineberg E, Evans DG, Jacobs C, Eeles RA, Adlard J, Davidson R, Eccles DM, Cole T, Cook J, Paterson J, Brewer C, Douglas F, Hodgson SV, Morrison PJ, Walker L, Porteous ME, Kennedy MJ, Side LE, Bove B, Godwin AK, Stoppa-Lyonnet D, Fassy-Colcombet M, Castera L, Cornelis F, Mazoyer S, Leone M, Boutry-Kryza N, Bressac-de Paillerets B, Caron O, Pujol P, Coupier I, Delnatte C, Akloul L, Lynch HT, Snyder CL, Buys SS, Daly MB, Terry M, Chung WK, John EM, Miron A, Southey MC, Hopper JL, Goldgar DE, Singer CF, Rappaport C, Tea MK, Fink-Retter A, Hansen TV, Nielsen FC, Arason A, Vijai J, Shah S, Sarrel K, Robson ME, Piedmonte M, Phillips K, Basil J, Rubinstein WS, Boggess J, Wakeley K, Ewart-Toland A, Montagna M, Agata S, Imyanitov EN, Isaacs C, Janavicius R, Lazaro C, Blanco I, Feliubadalo L, Brunet J, Gayther SA, Pharoah PP, Odunsi KO, Karlan BY, Walsh CS, Olah E, Teo SH, Ganz PA, Beattie MS, van Rensburg EJ, Dorfling CM, Diez O, Kwong A, Schmutzler RK, Wappenschmidt B, Engel C, Meindl A, Ditsch N, Arnold N, Heidemann S, Niederacher D, Preisler-Adams S, Gadzicki D, Varon-Mateeva R, Deissler H, Gehrig A, Sutter C, Kast K, Fiebig B, Heinritz W, Caldes T, de la Hoya M, Muranen TA, Nevanlinna H, Tischkowitz M, Spurdle AB, Neuhausen SL, Ding YC, Lindor NM, Fredericksen Z, Pankratz VS, Peterlongo P, Manoukian S, Peissel B, Zaffaroni D, Barile M, Bernard L, Viel A, Giannini G, Varesco L, Radice P, Greene MH, Mai PL, Easton DF, Chenevix-Trench G, Offit K, Simard J. Common Variants at the 19p13.1 and ZNF365 Loci Are Associated with ER Subtypes of Breast Cancer and Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers. Cancer Epidemiology Biomarkers & Prevention. 2012 Apr;21(4):645-57.   PMCID: PMC3319317
Ding YC, McGuffog L, Healey S, Friedman E, Laitman Y, Shani Paluch S, Kaufman B, Liljegren A, Lindblom A, Olsson H, Kristoffersson U, Stenmark-Askmalm M, Melin B, Domchek SM, Nathanson KL, Rebbeck TR, Jakubowska A, Lubinski J, Jaworska K, Durda K, Gronwald J, Huzarski T, Cybulski C, Byrski T, Osorio A, Cajal TR, Stavropoulou AV, Benitez J, Hamann U, Rookus M, Aalfs CM, de Lange JL, Meijers-Heijboer HE, Oosterwijk JC, van Asperen CJ, Garcia EB, Hoogerbrugge N, Jager A, van der Luijt RB, Easton DF, Peock S, Frost D, Ellis SD, Platte R, Fineberg E, Evans DG, Lalloo F, Izatt L, Eeles R, Adlard J, Davidson R, Eccles D, Cole T, Cook J, Brewer C, Tischkowitz M, Godwin AK, Pathak H, Stoppa-Lyonnet D, Sinilnikova OM, Mazoyer S, Barjhoux L, Leone M, Gauthier-Villars M, Caux-Moncoutier V, de Pauw A, Hardouin A, Berthet P, Dreyfus H, Ferrer SF, Collonge-Rame MA, Sokolowska J, Buys S, Daly M, Miron A, Terry MB, Chung W, John EM, Southey M, Goldgar D, Singer CF, Tea MK, Gschwantler-Kaulich D, Fink-Retter A, Hansen TV, Ejlertsen B, Johannsson OT, Offit K, Sarrel K, Gaudet MM, Vijai J, Robson M, Piedmonte MR, Andrews L, Cohn D, DeMars LR, DiSilvestro P, Rodriguez G, Toland AE, Montagna M, Agata S, Imyanitov E, Isaacs C, Janavicius R, Lazaro C, Blanco I, Ramus SJ, Sucheston L, Karlan BY, Gross J, Ganz PA, Beattie MS, Schmutzler RK, Wappenschmidt B, Meindl A, Arnold N, Niederacher D, Preisler-Adams S, Gadzicki D, Varon-Mateeva R, Deissler H, Gehrig A, Sutter C, Kast K, Nevanlinna H, Aittomaki K, Simard J, Spurdle AB, Beesley J, Chen XQ, Tomlinson GE, Weitzel J, Garber JE, Olopade OI, Rubinstein WS, Tung N, Blum JL, Narod SA, Brummel S, Gillen DL, Lindor N, Fredericksen Z, Pankratz VS, Couch FJ, Radice P, Peterlongo P, Greene MH, Loud JT, Mai PL, Andrulis IL, Glendon G, Ozcelik H, Gerdes AM, Thomassen M, Jensen UB, Skytte AB, Caligo MA, Lee A, Chenevix-Trench G, Antoniou AC, Neuhausen SL. A Nonsynonymous Polymorphism in IRS1 Modifies Risk of Developing Breast and Ovarian Cancers in BRCA1 and Ovarian Cancer in BRCA2 Mutation Carriers. Cancer Epidemiology Biomarkers & Prevention. 2012 Aug;21(8):1362-70.   PMCID: PMC3415567
Engel I, Zhao M, Kappes D, Taniuchi I, Kronenberg M. The transcription factor Th-POK negatively regulates Th17 differentiation in V alpha 14i NKT cells. Blood. 2012 Nov;120(23):4524-32.   PMCID: PMC3512232
Motzer RJ, Hutson TE, Olsen MR, Hudes GR, Burke JM, Edenfield WJ, Wilding G, Agarwal N, Thompson JA, Cella D, Bello A, Korytowsky B, Yuan JY, Valota O, Martell B, Hariharan S, Figlin RA. Randomized Phase II Trial of Sunitinib on an Intermittent Versus Continuous Dosing Schedule As First-Line Therapy for Advanced Renal Cell Carcinoma. Journal of Clinical Oncology. 2012 Apr;30(12):1371-7.   PMCID: not NIH funded
Skarbnik AP, Smith MR. Brentuximab vedotin in anaplastic large cell lymphoma. Expert Opinion on Biological Therapy. 2012 May;12(5):633-9.   PMCID: *
Smith ER, Yeasky T, Wei JQ, Miki RA, Cai KQ, Smedberg JL, Yang WL, Xu XX. White spotting variant mouse as an experimental model for ovarian aging and menopausal biology. Menopause-the Journal of the North American Menopause Society. 2012 May;19(5):588-96.   PMCID: PMC3326177
Tchou J, Wang LC, Selven B, Zhang HT, Conejo-Garcia J, Borghaei H, Kalos M, Vondeheide RH, Albelda SM, June CH, Zhang PJ. Mesothelin, a novel immunotherapy target for triple negative breast cancer. Breast Cancer Research and Treatment. 2012 Jun;133(2):799-804.
Gong Y, Huo L, Liu P, Sneige N, Sun X, Ueno NT, Lucci A, Buchholz TA, Valero V, Cristofanilli M. Polycomb group protein EZH2 is frequently expressed in inflammatory breast cancer and is predictive of worse clinical outcome. Cancer. 2011 Dec;117(24):5476-84.   PMCID: not NIH funded
Pectasides E, Rampias T, Kountourakis P, Sasaki C, Kowalski D, Fountzilas G, Zaramboukas T, Rimm D, Burtness B, Psyrri A. Comparative Prognostic Value of Epidermal Growth Factor Quantitative Protein Expression Compared with FISH for Head and Neck Squamous Cell Carcinoma. Clinical Cancer Research. 2011 May;17(9):2947-54.   PMCID: not NIH funded
Sparano JA, Goldstein LJ, Childs BH, Shak S, Brassard D, Badve S, Baehner FL, Bugarini R, Rowley S, Perez EA, Shulman LN, Martino S, Davidson NE, Kenny PA, Sledge GW, Gray R. Relationship between Quantitative GRB7 RNA Expression and Recurrence after Adjuvant Anthracycline Chemotherapy in Triple-Negative Breast Cancer. Clinical Cancer Research. 2011 Nov;17(22):7194-203.   PMCID: PMC3570203
Stadanlick JE, Zhang ZQ, Lee SY, Hemann M, Biery M, Carleton MO, Zambetti GP, Anderson SJ, Oravecz T, Wiest DL. Developmental Arrest of T Cells in Rpl22-Deficient Mice Is Dependent upon Multiple p53 Effectors. Journal of Immunology. 2011 Jul;187(2):664-75.   PMCID: PMC3131471
Boorjian SA, Zhu F, Herr HW. The effect of gender on response to bacillus Calmette-Guerin therapy for patients with non-muscle-invasive urothelial carcinoma of the bladder. BJU international. 2010 Aug;106(3):357-61.   PMCID: *
Burris HA, Rosen LS, Rocha-Lima CM, Marshall J, Jones S, Cohen RB, Kunkel LA, Loo D, Baughman J, Stewart SJ, Lewis N. Phase 1 Experience with an Anti-Glycotope Monoclonal Antibody, RAV12, in Recurrent Adenocarcinoma. Clinical Cancer Research. 2010 Mar;16(5):1673-81.   PMCID: not NIH funded
Hsu PY, Hsu HK, Singer GA, Yan PS, Rodriguez BA, Liu JC, Weng YI, Deatherage DE, Chen Z, Pereira JS, Lopez R, Russo J, Wang QB, Lamartiniere CA, Nephew KP, Huang TH. Estrogen-mediated epigenetic repression of large chromosomal regions through DNA looping. Genome Research. 2010 Jun;20(6):733-44.   PMCID: PMC2877570
Jin Y, Xia MC, Saylor CM, Narayan K, Kang J, Wiest DL, Wang YM, Xiong N. Cutting Edge: Intrinsic Programming of Thymic gamma delta T Cells for Specific Peripheral Tissue Localization. Journal of Immunology. 2010 Dec;185(12):7156-60.   PMCID: PMC3023158
Kelly DF, Lake RJ, Middelkoop TC, Fan HY, Artavanis-Tsakonas S, Walz T. Molecular Structure and Dimeric Organization of the Notch Extracellular Domain as Revealed by Electron Microscopy. Plos One. 2010 May;5(5).   PMCID: PMC2866536
Tong X, Zitserman D, Serebriiskii I, Andrake M, Dunbrack R, Roegiers F. Numb Independently Antagonizes Sanpodo Membrane Targeting and Notch Signaling in Drosophila Sensory Organ Precursor Cells. Molecular Biology of the Cell. 2010 Mar;21(5):802-10.   PMCID: PMC2828966 (available 5/16/2010)
van Rhee F, Fayad L, Voorhees P, Furman R, Lonial S, Borghaei H, Sokol L, Crawford J, Cornfeld M, Qi M, Qin XA, Herring J, Casper C, Kurzrock R. Siltuximab, a Novel Anti-Interleukin-6 Monoclonal Antibody, for Castleman's Disease. Journal of Clinical Oncology. 2010 Aug;28(23):3701-8.   PMCID: Not required
Pollack A, Bae K, Khor LY, Al-Saleem T, Hammond ME, Venkatesan V, Byhardt RW, Asbell SO, Shipley WU, Sandler HM. The Importance of Protein Kinase A in Prostate Cancer: Relationship to Patient Outcome in Radiation Therapy Oncology Group Trial 92-02. Clinical Cancer Research. 2009 Sep;15(17):5478-84.   PMCID: PMC2763098
Zhou Y, Daryl C, Zou H, Hayes ME, Adams GP, Kirpotin DB, Marks JD. Impact of single-chain fv antibody fragment affinity on nanoparticle targeting of epidermal growth factor receptor-expressing tumor cells. Journal of Molecular Biology. 2007 Aug;371(4):934-47.
Altomare DA, You HH, Xiao GH, Ramos-Nino ME, Skele KL, De Rienzo A, Jhanwar SC, Mossman BT, Kane AB, Testa JR. Human and mouse mesotheliomas exhibit elevated AKT/PKB activity, which can be targeted pharmacologically to inhibit tumor cell growth. Oncogene. 2005 Sep 08;24(40):6080-9.
Bookman MA. Is there still a role for hormonal therapy?. International Journal of Gynecological Cancer. 2005 Nov 03;15:291-7.
Daley JK, Gechman LA, Skipworth J, Rall GF. Poliovirus replication and spread in primary neuron cultures. Virology. 2005 Sep 15;340(1):10-20.
Jordan VC, Lewis JS, Osipo C, Cheng D. The apoptotic action of estrogen following exhaustive antihormonal therapy: A new clinical treatment strategy. Breast. 2005 Dec;14(6):624-30.
Osipo C, Gajdos C, Cheng D, Jordan VC. Reversal of tamoxifen resistant breast cancer by low dose estrogen therapy. Journal of Steroid Biochemistry and Molecular Biology. 2005 Feb;93(2-5):249-56.
Park WC, Liu H, Schafer JM, Jordan VC. Deregulation of estrogen induced telomerase activity in tamoxifen-resistant breast cancer cells. International Journal of Oncology. 2005 Nov;27(5):1459-66.
Beauparlant SL, Read PW, Di Cristofano A. In vivo adenovirus-mediated gene transduction into mouse endometrial glands: a novel tool to model endometrial cancer in the mouse. Gynecologic Oncology. 2004 Sep;94(3):713-8.
Bono P, Krause A, von Mehren M, Heinrich MC, Blanke CD, Dimitrijevic S, Demetri GD, Joensuu H. Serum KIT and KIT ligand levels in patients with gastrointestinal stromal tumors treated with imatinib. Blood. 2004 Apr;103(8):2929-35.
Rall GF. Measles virus 1998-2002: progress and controversy. Annu Rev Microbiol. 2003 Jan;57:343-67.
Bowman EP, Campbell JJ, Soler D, Dong ZJ, Manlongat N, Picarella D, Hardy RR, Butcher EC. Developmental switches in chemokine response profiles during B cell differentiation and maturation. Journal of Experimental Medicine. 2000 Apr 17;191(8):1303-17.
Burdin N, Brossay L, Degano M, Iijima H, Gui M, Wilson IA, Kronenberg M. Structural requirements for antigen presentation by mouse CD1. Proceedings of the National Academy of Sciences of the United States of America. 2000 Aug 29;97(18):10156-61.
Dadke SS, Li HC, Kusari AB, Begum N, Kusari J. Elevated expression and activity of protein-tyrosine phosphatase 1B in skeletal muscle of insulin-resistant type II diabetic Goto-Kakizaki rats. Biochemical and Biophysical Research Communications. 2000 Aug 11;274(3):583-9.
Liu XH, Elia AE, Law SF, Golemis EA, Farley J, Wang TW. A novel ability of Smad3 to regulate proteasomal degradation of a Cas family member HEF1. Embo Journal. 2000 Dec 15;19(24):6759-69.
Mandik-Nayak L, Seo SJ, Eaton-Bassiri A, Allman D, Hardy RR, Erikson J. Functional consequences of the developmental arrest and follicular exclusion of anti-double-stranded DNA B cells. Journal of Immunology. 2000 Feb;164(3):1161-8.
Miyake S, Sellers WR, Safran M, Li XT, Zhao WQ, Grossman SR, Gan JM, DeCaprio JA, Adams PD, Kaelin WG. Cells degrade a novel inhibitor of differentiation with E1A- like properties upon exiting the cell cycle. Molecular and Cellular Biology. 2000 Dec;20(23):8889-902.
Poul MA, Becerril B, Nielsen UB, Morisson P, Marks JD. Selection of tumor-specific internalizing human antibodies from phage libraries. Journal of Molecular Biology. 2000 Sep;301(5):1149-61.
Schurmann A, Mooney AF, Sanders LC, Sells MA, Wang HG, Reed JC, Bokoch GM. p21-activated kinase 1 phosphorylates the death agonist Bad and protects cells from apoptosis. Molecular and Cellular Biology. 2000 Jan;20(2):453-61.
Sheng ZJ, Sun WP, Smith E, Cohen C, Sheng Z, Xu XX. Restoration of positioning control following Disabled-2 expression in ovarian and breast tumor cells. Oncogene. 2000 Oct 05;19(42):4847-54.
Carleton M, Ruetsch NR, Berger MA, Rhodes M, Kaptik S, Wiest DL. Signals transduced by CD3 epsilon, but not by surface pre-TCR complexes, are able to induce maturation of an early thymic lymphoma in vitro. Journal of Immunology. 1999 Sep;163(5):2576-85.
Segal DM, Weiner GJ, Weiner LM. Bispecific antibodies in cancer therapy. Current Opinion in Immunology. 1999 Oct;11(5):558-62.
Tricoli JV, Winter DL, Hanlon AL, Raysor SL, Watkins-Bruner D, Pinover WH, Hanks GE. Racial differences in insulin-like growth factor binding protein-3 in men at increased risk of prostate cancer. Urology. 1999 Jul;54(1):178-82.
Yang YL, Guo L, Xu SA, Holland CA, Kitamura T, Hunter K, Cunningham JM. Receptors for polytropic and xenotropic mouse leukaemia viruses encoded by a single gene at Rmc1. Nature genetics. 1999 Feb;21(2):216-9.
Coppola D, Hyacinthe M, Fu L, Cantor AB, Karl R, Marcet J, Cooper DL, Nicosia SV, Cooper HS. CD44V6 expression in human colorectal carcinoma. Human Pathology. 1998 Jun;29(6):627-35.
Dave VP, Allman D, Keefe R, Hardy RR, Kappes DJ. HD mice: A novel mouse mutant with a specific defect in the generation of CD4(+) T cells. Proceedings of the National Academy of Sciences of the United States of America. 1998 Jul 07;95(14):8187-92.
Graves JD, Gotoh Y, Draves KE, Ambrose D, Han DK, Wright M, Chernoff J, Clark EA, Krebs EG. Caspase-mediated activation and induction of apoptosis by the mammalian Ste20-like kinase Mst1. Embo Journal. 1998 Apr 15;17(8):2224-34.
Holroyd KJ, Martinati LC, Trabetti E, Scherpbier T, Eleff SM, Boner AL, Pignatti PF, Kiser MB, Dragwa CR, Hubbard F, Sullivan CD, Grasso L, Messler CJ, Huang MX, Hu Y, Nicolaides NC, Buetow KH, Levitt RC. Asthma and bronchial hyperresponsiveness linked to the XY long arm pseudoautosomal region. Genomics. 1998 Sep;52(2):233-5.
Liu F, Sells MA, Chernoff J. Protein tyrosine phosphatase 1B negatively regulates integrin signaling. Current Biology. 1998 Jan 29;8(3):173-6.
Ma JG, Fei ZL, Klein-Szanto A, Gallo JM. Modulation of angiogenesis by human glioma xenograft models that differentially express vascular endothelial growth factor. Clinical & Experimental Metastasis. 1998 Aug;16(6):559-68.
Posern G, Zheng J, Knudsen BS, Kardinal C, Muller KB, Voss J, Shishido T, Cowburn D, Cheng GH, Wang BL, Kruh GD, Burrell SK, Jacobson CA, Lenz DM, Zamborelli TJ, Adermann K, Hanafusa H, Feller SM. Development of highly selective SH3 binding peptides for Crk and CRKL which disrupt Crk-complexes with DOCK180, SoS and C3G. Oncogene. 1998 Apr 16;16(15):1903-12.
Tumang JR, Owyang A, Andjelic S, Jin Z, Hardy RR, Liou ML, Liou HC. c-Rel is essential for B lymphocyte survival and cell cycle progression. European Journal of Immunology. 1998 Dec;28(12):4299-312.
Guo JT, Pugh JC. Topology of the large envelope protein of duck hepatitis B virus suggests a mechanism for membrane translocation during particle morphogenesis. Journal of Virology. 1997 Feb;71(2):1107-14.
Sattler M, Salgia R, Shrikhande G, Verma S, Uemura P, Law SF, Golemis EA, Griffin JD. Differential signaling after beta 1 integrin ligation is mediated through binding of CRKL to p120(CBL) and p110(HEF1). Journal of Biological Chemistry. 1997 May 30;272(22):14320-6.
Krop I, deFougerolles AR, Hardy RR, Allison M, Schlissel MS, Fearon DT. Self-renewal of B-1 lymphocytes is dependent on CD19. European Journal of Immunology. 1996 Jan;26(1):238-42.
Mann EA, Swenson ES, Copeland NG, Gilbert DJ, Jenkins NA, Taguchi T, Testa JR, Giannella RA. Localization of the guanylyl cyclase C gene to mouse chromosome 6 and human chromosome 12p12. Genomics. 1996 Jun;34(2):265-7.
Adams GP, McCartney JE, Wolf EJ, Eisenberg J, Huston JS, Bookman MA, Moldofsky P, Stafford WF, Houston LL, Weiner LM. Enhanced Tumor Specificity of 741f8-1(Sfv')(2), an Anti-C-Erbb- 2 Single-Chain Fv Dimer, Mediated by Stable Radioiodine Conjugation. Journal of Nuclear Medicine. 1995 Dec;36(12):2276-81.
Bagrodia S, Taylor SJ, Creasy CL, Chernoff J, Cerione RA. Identification of a Mouse P21(Cdc42/Rac) Activated Kinase. Journal of Biological Chemistry. 1995 Sep 29;270(39):22731-7.
Billups KL, Sherley JL, Palladino MA, Tindall JW, Roberts KP. Evidence for E-Selectin Complement Regulatory Domain Messenger- Rna Splice Variants in the Rat. Journal of Laboratory and Clinical Medicine. 1995 Dec;126(6):580-7.
Brilliant MH, Ching A, Nakatsu Y, Eicher EM. The Original Pink-Eyed Dilution Mutation-(P) Arose in Asiatic Mice - Implications for the H4 Minor Histocompatibility Antigen, Myod1 Regulation and the Origin of Inbred Strains. Genetics. 1994 Sep;138(1):203-11.
Kariv I, Hardy RR, Hayakawa K. 2 Distinct Non-T Helper Type-2 Interleukin-4(+) Cell Subsets in Mice as Revealed by Single-Cell Cytokine Analysis. European Journal of Immunology. 1994 Mar;24(3):549-57.
Spanopoulou E, Roman CA, Corcoran LM, Schlissel MS, Silver DP, Nemazee D, Nussenzweig MC, Shinton SA, Hardy RR, Baltimore D. Functional Immunoglobulin Transgenes Guide Ordered B-Cell Differentiation in Rag-1-Deficient Mice. Genes & development. 1994 May;8(9):1030-42.
Yeung RS. Management of Recurrent Cutaneous Melanoma. Current Problems in Cancer. 1994 May;18(3):143-86.
Gilks CB, Bear SE, Grimes HL, Tsichlis PN. Progression of Interleukin-2 (Il-2)-Dependent Rat T-Cell Lymphoma Lines to Il-2-Independent Growth Following Activation of a Gene (Gfi-1) Encoding a Novel Zinc Finger Protein. Molecular and Cellular Biology. 1993 Mar;13(3):1759-68.
Kotloff DB, Bosma MJ, Ruetsch NR. Scid Mouse Pre-B Cells with Intracellular Mu-Chains - Analysis of Recombinase Activity and Igh Gene Rearrangements. International Immunology. 1993 Apr;5(4):383-91.
Shiang R, Lidral AC, Ardinger HH, Buetow KH, Romitti PA, Munger RG, Murray JC. Association of Transforming Growth-Factor Alpha-Gene Polymorphisms with Nonsyndromic Cleft-Palate Only (Cpo). American Journal of Human Genetics. 1993 Oct;53(4):836-43.
Depalazzo IG, Holmes M, Gerceltaylor C, Weiner LM. Antitumor Effects of a Bispecific Antibody Targeting Ca19-9 Antigen and Cd16. Cancer Research. 1992 Oct 15;52(20):5713-9.
Harrington J, Hsieh CL, Gerton J, Bosma G, Lieber MR. Analysis of the Defect in DNA End Joining in the Murine Scid Mutation. Molecular and Cellular Biology. 1992 Oct;12(10):4758-68.
Larue L, Dougherty N, Porter S, Mintz B. Spontaneous Malignant Transformation of Melanocytes Explanted from W(F)/W(F) Mice with a Kit Kinase-Domain Mutation. Proceedings of the National Academy of Sciences of the United States of America. 1992 Aug 15;89(16):7816-20.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term receptor

receptor expression protein gene mice survival cancer apoptosis cells kinase antigen family in-vivo activation phosphorylation breast-cancer randomized-trial binding proteins identification disease tamoxifen monoclonal-antibody tyrosine phosphorylation tumor- postmenopausal women locus tyrosine amplification alpha-beta growth bone-marrow breast cancer messenger-rna mice lacking estrogen inhibitor localization carcinoma tyrosine kinase peptide selection phase-ii trial suppression tumor progression growth-factor-i carcinogenesis focal adhesion kinase murine leukemia-virus in-vitro mouse B lymphocyte product athymic mice recognition positive selection infection phosphatidylinositol 3-kinase lymphocytes genes targeted disruption subunit fragments protein-kinase lineage construction epithelial-cells domain sequences downstream cell-lines pathogenesis integrin negative selection histone methyltransferase ezh2 c-crk SUBACUTE SCLEROSING-PANENCEPHALITIS single chain Fv hematopoiesis combined immune-deficiency Breast cancer subtypes Mesothelin-Triple negative breast cancer-Chimeric antigen receptor-Immunotherapy alpha-galactosylceramide docking protein adapter proteins development in-vivo alleles phosphorylates overexpression rho t- endocytic protein regions memory t-cell-receptor rearrangement coding segments induced apoptosis human epidermal growth factor receptor 2 transitional-cell carcinoma cell positioning display library pak1 human-lymphocytes therapy features hairless gene rearrangement in-situ mouse models pre-tcr perimenopause fulvestrant autoimmune mice metastatic malignant-melanoma spotting w locus hormone therapy tumor targeting endocrine therapy crystal-structure tamoxifen ER-estradiol-breast cancer region rat uterus domains leaky scid mice membrane disruption y-chromosome immunotherapy embryonic stem-cells light-chain protein-tyrosine kinase fv adenoviral oncoprotein e1a VIRAL-RNA SYNTHESIS enhancer nk t-cells cd4(+) t- plus cetuximab non-hodgkins-lymphoma central tissue microarray analysis k1 urothelial cell signal-transduction neu-overexpressing metastatic breast rel tumor localization united-states copy number alterations sex steroids
Last updated on Thursday, August 02, 2018